The J&J vaccine delay: Brown University’s Dr. Ashish Jha Says minimal clot risk shouldn’t inhibit vaccine uptake
April 16, 202111:13 am
< a min read
This content is provided by Community Health Center, Inc.
This week hosts Mark Masselli and Margaret Flinter welcome Dr. Ashish Jha, Dean of the Brown University School of Public Health. Dr. Jha is a world renowned expert on pandemic preparedness and addresses concerns around the rare blood clot risk with the J&J vaccine, saying the brief pause in distribution is further evidence our scientific surveillance is working. He addresses the challenges of vaccine hesitancy and global supply chain. And also talks about the pandemic’s impact on propelling meaningful change in public health in the U.S. as well as in the global health infrastructure.